News

Approximately 300 million people worldwide are chronically infected with the hepatitis B virus (HBV) and at high risk of developing liver cirrhosis or hepatocellular carcinoma. Consequently, there is

More than one billion people worldwide are at risk of illness, disfigurement, disability, and even death from neglected tropical diseases (NTDs). Especially in the poorest regions of the world where

Prof Anna Hirsch from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) has now succeeded in acquiring a coveted European Research Council (ERC) grant for the second time. Under the

Bacteria of the genus Enterobacter are among the most dangerous bacteria associated with hospital infections worldwide. Some of their representatives are highly resistant to commonly used antibiotics

The hospital germ Pseudomonas aeruginosa forms biofilms, a kind of mucus layer, to protect itself from attack by the immune system or antibiotics. To form this sticky layer, as well as to successfully

With INCATE (INCubator for Antibacterial Therapies in Europe), the German Center for Infection Research (DZIF) has participated in the foundation of a European initiative to take up the fight against

Hepatitis B virus (HBV) infections remain a major global health problem – according to the World Health Organization (WHO) there are around 300 million HBV carriers worldwide. Current treatments

The 2022 Prize for Translational Infection Research of the German Center for Infection Research (DZIF), endowed with 5,000 euros, goes to the DZIF scientist and epidemiologist Gérard Krause. Prof

How widespread is the pathogenic gastric bacterium Helicobacter pylori in the German population? In the study "Helicobacter pylori prevalence, therapy success, resistance" (HelicoPTER), for which

The prevention and treatment of human immunodeficiency virus (HIV) infections has made great strides in recent years. At the same time, however, new challenges are emerging, for example in connection